Patents Assigned to Beijing Kaizheng Biotech Development Co. LTD
  • Publication number: 20160250339
    Abstract: A pegylated artesunate derivative, a pharmaceutical composition and uses thereof, the pegylated artesunate derivative is represented by the general formula (I): The pegylated artesunate derivative has activity comparable to that of artesunate, increased water solubility and stability, and an extended half-life in vivo.
    Type: Application
    Filed: April 12, 2013
    Publication date: September 1, 2016
    Applicants: Beijing Kaizheng Biotech Development Co. LTD, Institute of Pharmacology and Toxicology Academy of Military Medical Sciences PLA China, Institute of Pharmacology and Toxicology Academy of Military Medical Sciences PLA China
    Inventors: Sicheng Li, Qingbin Meng, Junwen Mao, Jinfeng Li, An Xu, Jia Liu, Yuanjun Liang, Qiyan Jia, Jiufeng Yan, Xiaoyang Shen, Hui Liu, Na Xing